1. Home
  2. ATHA vs ZEO Comparison

ATHA vs ZEO Comparison

Compare ATHA & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • ZEO
  • Stock Information
  • Founded
  • ATHA 2011
  • ZEO 2005
  • Country
  • ATHA United States
  • ZEO United States
  • Employees
  • ATHA N/A
  • ZEO N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • ZEO
  • Sector
  • ATHA Health Care
  • ZEO
  • Exchange
  • ATHA Nasdaq
  • ZEO NYSE
  • Market Cap
  • ATHA 21.0M
  • ZEO 19.5M
  • IPO Year
  • ATHA 2020
  • ZEO N/A
  • Fundamental
  • Price
  • ATHA $0.29
  • ZEO $1.70
  • Analyst Decision
  • ATHA Buy
  • ZEO
  • Analyst Count
  • ATHA 4
  • ZEO 0
  • Target Price
  • ATHA $11.25
  • ZEO N/A
  • AVG Volume (30 Days)
  • ATHA 206.7K
  • ZEO 1.2M
  • Earning Date
  • ATHA 05-14-2025
  • ZEO 05-14-2025
  • Dividend Yield
  • ATHA N/A
  • ZEO N/A
  • EPS Growth
  • ATHA N/A
  • ZEO N/A
  • EPS
  • ATHA N/A
  • ZEO N/A
  • Revenue
  • ATHA N/A
  • ZEO $77,582,314.00
  • Revenue This Year
  • ATHA N/A
  • ZEO N/A
  • Revenue Next Year
  • ATHA N/A
  • ZEO N/A
  • P/E Ratio
  • ATHA N/A
  • ZEO N/A
  • Revenue Growth
  • ATHA N/A
  • ZEO N/A
  • 52 Week Low
  • ATHA $0.22
  • ZEO $1.05
  • 52 Week High
  • ATHA $3.67
  • ZEO $5.25
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 49.02
  • ZEO 49.01
  • Support Level
  • ATHA $0.22
  • ZEO $1.26
  • Resistance Level
  • ATHA $0.30
  • ZEO $1.77
  • Average True Range (ATR)
  • ATHA 0.03
  • ZEO 0.27
  • MACD
  • ATHA 0.01
  • ZEO 0.03
  • Stochastic Oscillator
  • ATHA 79.22
  • ZEO 25.52

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

Share on Social Networks: